grant

Developing novel selective glycine receptor potentiators as a means to control pain. [ 2010 - 2013 ]

Also known as: New molecules to control chronic inflammatory pain

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/631448]

Researchers: Prof Rob Capon (Principal investigator) ,  Prof Joseph Lynch

Brief description It has been estimated that >3M Australians suffer from pain at a cost to the economy of >$34B, with chronic pain (persisting beyond 1-6 mths) accounting for ~half this burden. There is an urgent and compelling social and economic case for the development of safer and more effective pain therapeutics. This project takes inspiration from a new class of Australian marine natural products that selectively regulate a key pain pathway, and will optimize and develop these as a new class of pain drug.

Funding Amount $AUD 552,647.42

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]